TargetMol
Aloxistatin is an inhibitor of cysteine protease with blood platelet aggregation inhibiting activity. Aloxistatin is an irreversible, membrane-permeable inhibitor of lysosomal and cytosolic cysteine proteases with the ability to inhibit calpain activity in intact platelets.
More Information
Supplier Page
TargetMol
Aloxistatin is an inhibitor of cysteine protease with blood platelet aggregation inhibiting activity. Aloxistatin is an irreversible, membrane-permeable inhibitor of lysosomal and cytosolic cysteine proteases with the ability to inhibit calpain activity in intact platelets.
More Information
Supplier Page
TargetMol
BMH-21
5 mg
| 99.47%
TargetMol
BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.
More Information
Supplier Page
BMH-21
25 mg
| 99.47%
TargetMol
BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.
More Information
Supplier Page
BMH-21
100 mg
| 99.47%
TargetMol
BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.
More Information
Supplier Page
BMH-21
200 mg
| 99.47%
TargetMol
BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.
More Information
Supplier Page
TargetMol
Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.
More Information
Supplier Page
JNJ0966
5 mg
| Purity Not Available
TargetMol
JNJ0966
1 mg
| Purity Not Available
TargetMol